colchicine has been researched along with Chronic Kidney Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cheng, YJ; DU, YJ; Liu, WC | 1 |
| Chang, TI; Han, SH; Jhee, JH; Joo, YS; Kang, SW; Kim, HW; Kim, JY; Park, JT; Roh, YH; Yoo, TH; Yun, HR | 1 |
| Arazi, E; Landau, D; Segev, Y; Shukri, N; Tobar, A | 1 |
| Gaffo, A; Kannuthurai, V | 1 |
| Chapman, P; Frampton, C; Hamilton, G; Hudson, B; Judd, A; Stamp, LK | 1 |
| Georgin-Lavialle, S; Grateau, G; Stojanovic, KS | 1 |
| Aydoğ, Ö; Bülbül, M; Çakıcı, EK; Eroğlu, FK; Güngör, T; Gür, G; Özlü, SG; Yazılıtaş, F | 1 |
| Becker, MA; Castillo, M; Gunawardhana, L; Hunt, B; Kisfalvi, K; Saag, KG; Whelton, A | 1 |
| Ho, GCH; Lau, WH; Leung, MH | 1 |
| Kim, HW; Kim, JH; Lee, EB; Lee, EY; Lee, YJ; Ryu, HJ; Song, R; Song, YW | 1 |
| Chen, G; Chen, X; Gao, B; Guan, T; Ingram, AJ; Janssen, M; Krepinsky, JC; Uttarwar, L | 1 |
| Cheetham, TC; Levy, GD; Niu, F; Rashid, N | 1 |
| Bardin, T; Doherty, M; Jansen, TL; Nuki, G; Pascual, E; Perez-Ruiz, F; Punzi, L; Richette, P; So, AK | 1 |
| Stamp, LK | 1 |
| Ghang, B; Hong, S; Kim, YG; Kwon, OC; Lee, CK; Yoo, B | 1 |
| Crittenden, DB; Fisher, MC; Goldfarb, DS; Keenan, RT; Krasnokutsky, S; Lee, KH; O'Brien, WR; Oh, C; Pillinger, MH | 1 |
| Curiel, RV; Guzman, NJ | 1 |
| Abdel-Kaleek, E; Abdel-Rahim, M; Abdel-Shafy, E; Abo-Zena, H; El-Dahshan, K; El-Husseini, A; Sabry, A; Sheashaa, H | 1 |
| Dold, S; Espinoza, LR; Justiniano, M | 1 |
5 review(s) available for colchicine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Management of Patients with Gout and Kidney Disease: A Review of Available Therapies and Common Missteps.
Topics: Colchicine; Gout; Humans; Quality of Life; Renal Insufficiency, Chronic; Uric Acid | 2023 |
[AA amyloidosis].
Topics: Amyloidosis; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colchicine; Humans; Proteinuria; Renal Dialysis; Renal Insufficiency, Chronic; Tubulin Modulators | 2017 |
Improving cardiovascular and renal outcomes in gout: what should we target?
Topics: Allopurinol; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Disease Management; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Metabolic Syndrome; Probenecid; Renal Insufficiency, Chronic; Treatment Outcome; Uricosuric Agents; Xanthine Oxidase | 2014 |
Major unanswered questions in the clinical gout field.
Topics: Allopurinol; Benzbromarone; Colchicine; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Patient Care Planning; Probenecid; Renal Insufficiency, Chronic; Uric Acid; Uricosuric Agents | 2017 |
Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Comorbidity; Contraindications; Febuxostat; Glucocorticoids; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Probenecid; PubMed; Renal Insufficiency, Chronic; Secondary Prevention; Thiazoles; Urate Oxidase | 2012 |
1 trial(s) available for colchicine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Colchicine; Cough; Creatinine; Delayed-Action Preparations; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Febuxostat; Female; gamma-Glutamyltransferase; Glomerular Filtration Rate; Gout; Gout Suppressants; Headache; Humans; Hypertension; Male; Middle Aged; Naproxen; Nasopharyngitis; Renal Insufficiency, Chronic; Respiratory Tract Infections; Severity of Illness Index; Treatment Outcome; Uric Acid | 2019 |
14 other study(ies) available for colchicine and Chronic Kidney Diseases
| Article | Year |
|---|---|
[A case report of colchicine-induced myopathy in a patient with chronic kidney disease].
Topics: Colchicine; Gout; Humans; Kidney; Male; Middle Aged; Muscular Diseases; Renal Insufficiency, Chronic | 2021 |
Colchicine use and the risk of CKD progression: a multicentre nested case-control study.
Topics: Case-Control Studies; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Renal Insufficiency, Chronic; Treatment Outcome; Uric Acid | 2022 |
Beneficiary Effects of Colchicine on Inflammation and Fibrosis in a Mouse Model of Kidney Injury.
Topics: Adenine; Animals; Anti-Inflammatory Agents; Caspase 1; Colchicine; Disease Models, Animal; Fibrosis; Inflammation; Interleukin-1; Kidney; Mice; Mice, Inbred C57BL; Renal Insufficiency, Chronic; Tubulin | 2023 |
The challenges of managing gout in primary care: Results of a best-practice audit.
Topics: Aged; Allopurinol; Clinical Audit; Clinical Chemistry Tests; Clinical Protocols; Colchicine; Comorbidity; Diabetes Mellitus; Disease Management; Female; Gout; Gout Suppressants; Guideline Adherence; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Male; Mass Screening; Middle Aged; New Zealand; Obesity; Patient Education as Topic; Practice Guidelines as Topic; Primary Health Care; Referral and Consultation; Renal Insufficiency, Chronic; Rheumatology; Rural Population; Uric Acid | 2019 |
Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
Topics: Adolescent; Age Factors; Amyloidosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Colchicine; Drug Resistance; Familial Mediterranean Fever; Humans; Immunologic Factors; Renal Insufficiency, Chronic; Retrospective Studies; Time Factors; Treatment Outcome; Turkey; Uveitis | 2018 |
Colchicine gastrotoxicity in a patient with chronic kidney disease.
Topics: Aged; Biopsy; Colchicine; Endoscopy, Digestive System; Gastric Mucosa; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney; Male; Renal Insufficiency, Chronic | 2019 |
Clinical risk factors for adverse events in allopurinol users.
Topics: Adult; Aged; Allopurinol; Colchicine; Drug-Related Side Effects and Adverse Reactions; Female; Gout; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hyperuricemia; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Young Adult | 2013 |
Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease.
Topics: Animals; Cells, Cultured; Colchicine; Collagen Type I; Connective Tissue Growth Factor; Cytoprotection; Disease Models, Animal; Enzyme Activation; Fibronectins; Fibrosis; Hypertension, Renal; Kidney; Male; Microtubules; Nephrectomy; Nephritis; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; rhoA GTP-Binding Protein; Smad3 Protein; Stress, Mechanical; Transfection; Transforming Growth Factor beta | 2013 |
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Databases, Factual; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Uric Acid | 2014 |
Colchicine: more deaths.
Topics: Age Factors; Colchicine; Diarrhea; Drug Interactions; Gout; Gout Suppressants; Humans; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors | 2014 |
Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
Topics: Colchicine; Cytochrome P-450 CYP3A; Drug Administration Schedule; Female; Gout; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirrhosis; Male; Middle Aged; Muscular Diseases; Renal Insufficiency, Chronic; Risk Factors | 2017 |
Prevalence of contraindications and prescription of pharmacologic therapies for gout.
Topics: Aged; Aged, 80 and over; Allopurinol; Colchicine; Comorbidity; Contraindications; Diabetes Mellitus; Drug Prescriptions; Female; Gastroesophageal Reflux; Glucocorticoids; Gout; Gout Suppressants; Hepatitis, Chronic; Humans; Hypertension; Male; Middle Aged; Prevalence; Probenecid; Renal Insufficiency, Chronic; Severity of Illness Index; Uricosuric Agents | 2011 |
Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Sprague Dawley rats: an experimental animal model.
Topics: Animals; Colchicine; Creatinine; Cyclosporine; Fatty Acids, Omega-3; Immunosuppressive Agents; Kidney; Male; Potassium; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sodium; Tubulin Modulators; Vimentin | 2006 |
Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.
Topics: Arthritis, Gouty; Bursitis; Colchicine; Drug Synergism; Female; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Renal Insufficiency, Chronic; Rhabdomyolysis; Simvastatin | 2007 |